Inhibition of FAS or FASN expression has been previously shown to sensitize prostate cancer and non-small cell lung cancer cells to irradiation [26,27] However, FAS inhibition did not result in an increase in DNA damage or radiosensitization in HNSCC cell lines. The gene discussed is FAS; the disease is head and neck squamous cell carcinoma.